Sanofi’s SAR402663 Granted Fast Track Designation for Neovascular AMD in the US

Read more

Charles River Expands Oncology Manufacturing Through New Collaboration to Boost Cell and Gene Therapy R&D

Read more

Zentiva Announces Sale from Advent to GTCR

Read more

Tzield Approved in China as First Disease-Modifying Therapy for Stage 2 Type 1 Diabetes

Read more

Kriya Secures $320M Series D to Advance Gene Therapies for Chronic Diseases

Read more

CAPVAXIVE Shows Strong Immune Response in At-Risk Children and Teens

Read more

Kashiv BioSciences and CRISTÁLIA Sign Licensing and Supply Deal for Omalizumab Biosimilar in Latin America

Read more

Scipher Medicine and Maxymune Therapeutics Partner to Speed Autoimmune and Inflammatory Disease Target Discovery

Read more

Kytopen Partners with BlueWhale Bio to Transform Cell Therapy Manufacturing

Read more

FDA Launches Major Crackdown on Deceptive Drug Advertising

Read more